1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Minimally Invasive Surgical (MIS) Devices - Medical Devices Pipeline Assessment, 2016

Minimally Invasive Surgical (MIS) Devices - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, “Minimally Invasive Surgical (MIS) Devices - Medical Devices Pipeline Assessment, 2016" provides an overview of Minimally Invasive Surgical (MIS) Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Minimally Invasive Surgical (MIS) Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Minimally Invasive Surgical (MIS) Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Minimally Invasive Surgical (MIS) Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Minimally Invasive Surgical (MIS) Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table Of Contents

Minimally Invasive Surgical (MIS) Devices - Medical Devices Pipeline Assessment, 2016
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 8
2 Introduction 9
2.1 Minimally Invasive Surgical (MIS) Devices Overview 9
3 Products under Development 10
3.1 Minimally Invasive Surgical (MIS) Devices - Pipeline Products by Stage of Development 10
3.2 Minimally Invasive Surgical (MIS) Devices - Pipeline Products by Territory 11
3.3 Minimally Invasive Surgical (MIS) Devices - Pipeline Products by Regulatory Path 12
3.4 Minimally Invasive Surgical (MIS) Devices - Pipeline Products by Estimated Approval Date 13
3.5 Minimally Invasive Surgical (MIS) Devices - Ongoing Clinical Trials 14
4 Minimally Invasive Surgical (MIS) Devices - Pipeline Products under Development by Companies 15
4.1 Minimally Invasive Surgical (MIS) Devices Companies - Pipeline Products by Stage of Development 15
4.2 Minimally Invasive Surgical (MIS) Devices - Pipeline Products by Stage of Development 17
5 Minimally Invasive Surgical (MIS) Devices Companies and Product Overview 18
5.1 Actuated Medical, Inc. Company Overview 18
5.1.1 Actuated Medical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 18
5.2 BriteSeed Company Overview 20
5.2.1 BriteSeed Pipeline Products and Ongoing Clinical Trials Overview 20
5.3 Delft University of Technology Company Overview 21
5.3.1 Delft University of Technology Pipeline Products and Ongoing Clinical Trials Overview 21
5.4 DistalMotion Company Overview 24
5.4.1 DistalMotion Pipeline Products and Ongoing Clinical Trials Overview 24
5.5 ES Vascular Ltd. Company Overview 26
5.5.1 ES Vascular Ltd. Pipeline Products and Ongoing Clinical Trials Overview 26
5.6 Ethicon Endo-Surgery, Inc. Company Overview 27
5.6.1 Ethicon Endo-Surgery, Inc. Pipeline Products and Ongoing Clinical Trials Overview 27
5.7 Eximis Company Overview 28
5.7.1 Eximis Pipeline Products and Ongoing Clinical Trials Overview 28
5.8 FlexDex Company Overview 29
5.8.1 FlexDex Pipeline Products and Ongoing Clinical Trials Overview 29
5.9 Fortimedix B.V. Company Overview 31
5.9.1 Fortimedix B.V. Pipeline Products and Ongoing Clinical Trials Overview 31
5.10 Hadassah Medical Center Company Overview 32
5.10.1 Hadassah Medical Center Pipeline Products and Ongoing Clinical Trials Overview 32
5.11 Human Extensions LTD Company Overview 33
5.11.1 Human Extensions LTD Pipeline Products and Ongoing Clinical Trials Overview 33
5.12 Imperial College London Company Overview 34
5.12.1 Imperial College London Pipeline Products and Ongoing Clinical Trials Overview 34
5.13 John Hopkins University Company Overview 35
5.13.1 John Hopkins University Pipeline Products and Ongoing Clinical Trials Overview 35
5.14 Osaka University Company Overview 36
5.14.1 Osaka University Pipeline Products and Ongoing Clinical Trials Overview 36
5.15 Rambam Health Care Campus Company Overview 37
5.15.1 Rambam Health Care Campus Pipeline Products and Ongoing Clinical Trials Overview 37
5.16 Signum Surgical Ltd Company Overview 38
5.16.1 Signum Surgical Ltd Pipeline Products and Ongoing Clinical Trials Overview 38
5.17 Technische Universiteit Eindhoven Company Overview 39
5.17.1 Technische Universiteit Eindhoven Pipeline Products and Ongoing Clinical Trials Overview 39
5.18 UltraSurge Technologies Ltd. Company Overview 40
5.18.1 UltraSurge Technologies Ltd. Pipeline Products and Ongoing Clinical Trials Overview 40
5.19 University of California, San Francisco Company Overview 41
5.19.1 University of California, San Francisco Pipeline Products and Ongoing Clinical Trials Overview 41
5.20 University of Wisconsin Madison Company Overview 45
5.20.1 University of Wisconsin Madison Pipeline Products and Ongoing Clinical Trials Overview 45
5.21 Varada Innovations Inc. Company Overview 47
5.21.1 Varada Innovations Inc. Pipeline Products and Ongoing Clinical Trials Overview 47
5.22 VenX Medical LLC Company Overview 48
5.22.1 VenX Medical LLC Pipeline Products and Ongoing Clinical Trials Overview 48
5.23 XACT Robotics Ltd. Company Overview 51
5.23.1 XACT Robotics Ltd. Pipeline Products and Ongoing Clinical Trials Overview 51
6 Minimally Invasive Surgical (MIS) Devices- Recent Developments 52
6.1 Oct 26, 2016: LeMaitre Q3 2016 Record Sales $23.2 mm (+22%), Record Op. Income $5.3 mm (+61%) 52
6.2 Oct 26, 2016: Life Spine Achieves 32% Sales Growth and Announces Industry's Largest Post-Packing Capabilities for Lateral Fusion 52
6.3 Oct 18, 2016: Intuitive Surgical Announces Third Quarter Earnings 53
6.4 Oct 17, 2016: Fortimedix Surgical Announces the U.S. Launch of symphonX Surgical Platform, the World's Lowest Profile Single-Port Surgery Solution, During American College of Surgeons Clinical Congress 2016 54
6.5 Oct 17, 2016: Syneron Medical Strengthens Senior Management Team 54
6.6 Oct 17, 2016: Syneron Medical Announces Preliminary Third Quarter 2016 Revenue 55
6.7 Oct 10, 2016: Fortimedix Surgical Announces Successful Completion of First-In-Man Laparoscopic Cholecystectomy with FMX314, the World's Lowest Profile Single-Port Surgery Solution, in the United States 55
6.8 Oct 03, 2016: Fortimedix Surgical Announces CE Mark Approval for FMX314, the World's Lowest Profile Single-Port Surgery Solution 56
6.9 Oct 03, 2016: miVIP Reveals Robot-Assisted Gynecological Techniques to Surgeons Worldwide 56
6.10 Sep 30, 2016: MagForce Publishes Financial Results for the First Half of 2016 and Operative Highlights 57
6.11 Sep 27, 2016: Titan Medical Provides Corporate Update 59
6.12 Sep 16, 2016: Incisionless Robotic Surgery Offers Promising Outcomes for Oropharyngeal Cancer 59
6.13 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 60
6.14 Sep 08, 2016: Titan Medical Raises USD8 Million in Public Offering of Units 61
6.15 Sep 06, 2016: DJO Global Announces Appointment of Mike Eklund as Chief Operating Officer and Chief Financial Officer 61
6.16 Aug 31, 2016: Cook Medical Names Jean-Marc Creissel Vice President of Operations in Greater China 62
6.17 Aug 31, 2016: Surgical Innovations Group: Interim results for the six months ended 30 June 2016 62
6.18 Aug 29, 2016: Fortimedix Surgical Announces 510(k) Clearance for Innovative Single-port Surgical Platform 64
6.19 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 64
6.20 Aug 16, 2016: New Study Shows Robotic-Assisted Surgery Benefits For Ventral Hernia Patients 67
6.21 Aug 15, 2016: MRI Interventions Announces 2016 Second Quarter and Six Month Results 68
6.22 Aug 15, 2016: Titan Medical Reports Second Quarter Financial Results and Provides SPORT Surgical System Development Update 72
6.23 Aug 10, 2016: MagForce announces positive results of 2016 Annual General Meeting 72
6.24 Aug 05, 2016: TransEnterix Reports Operating Results for the Second Quarter 2016 73
6.25 Aug 04, 2016: BDCH First to Offer Robot-Assisted Surgery in Dodge County Region 73
6.26 Aug 04, 2016: Syneron Medical Reports Second Quarter 2016 Revenue of $75.0 Million and Non-GAAP EPS of $0.09 74
6.27 Aug 03, 2016: miVIP Surgery Centers Is Pleased to Open Its Doors to Experienced Physicians Seeking Information, Experience and Training With the New da Vinci Xi Surgical System 75
6.28 Aug 02, 2016: Encision Reports First Quarter Fiscal Year 2017 Results 76
6.29 Jul 28, 2016: DJO Global Announces Financial Results for Second Quarter 2016 76
6.30 Jul 28, 2016: Integra LifeSciences Reports Second Quarter 2016 Financial Results 77
6.31 Jul 27, 2016: LeMaitre Q2 2016 Record Sales $22.4mm (+13%), Record Op. Income $3.8mm (+35%) 79
6.32 Jul 26, 2016: Globus Medical Reports Second Quarter 2016 Results 79
6.33 Jul 21, 2016: Stryker reports second quarter 2016 results 80
6.34 Jul 19, 2016: Intuitive Surgical Announces Second Quarter Earnings 81
6.35 Jul 18, 2016: Life Spine Achieves Unparalleled Financial Results and a 50% Sales Growth Rate in Q2 2016 82
6.36 Jun 30, 2016: MagForce Publishes Financial Results for the Year 2015 and Operative Highlights 82
6.37 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 84
6.38 Jun 20, 2016: Gynecology Cases Performed Successfully with FMX314 Surgical Platform 84
6.39 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 85
6.40 Jun 01, 2016: Titan Medical to Raise USD16 Million in Private Placement of Shares 85
6.41 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 86
6.42 May 26, 2016: Centerline Biomedical Plans to Raise Funds in Series A Financing 88
6.43 May 25, 2016: TransEnterix Appoints Theodore Pappas, MD Senior Surgical Officer 88
6.44 May 23, 2016: Vicarious Surgical Raises USD1 Million in Venture Financing 89
6.45 May 19, 2016: Syneron Medical Reports First Quarter 2016 Revenue of $68.7 Million 89
6.46 May 16, 2016: Titan Medical Reports First Quarter Financial Results and Provides Corporate Update 90
6.47 May 13, 2016: Encision Reports Fourth Quarter and Fiscal Year 2016 Results 92
6.48 May 10, 2016: TransEnterix Reports Operating Results for the First Quarter 2016 93
6.49 May 10, 2016: DJO Global Announces Financial Results for First Quarter 2016 93
6.50 May 04, 2016: Life Spine Announces Twenty New Innovations in 2016, Record Growth in First Quarter 94
6.51 May 03, 2016: Globus Medical Reports First Quarter 2016 Results 95
6.52 May 02, 2016: LeMaitre Q1 2016 Sales $20.3mm (+7%), Op. Inc. $3.3mm (+43%) 95
6.53 Apr 28, 2016: Life Spine to Host PULSE Lab and Attend AANS Where They Will Showcase Key Additions to Their Twenty New Innovations Launching in 2016 96
6.54 Apr 28, 2016: MRI Interventions Announces 2016 First Quarter Results 96
6.55 Apr 08, 2016: DJO Global Announces Planned Transition of CFO, Susan Crawford 98
6.56 Mar 30, 2016: Titan Medical Reports Financial Results for Fiscal Year Ended December 31, 2015 98
6.57 Mar 25, 2016: DJO Global Announces Financial Results for Fourth Quarter and Fiscal Year End 2015 99
6.58 Mar 24, 2016: Fortimedix Surgical Announces 510(k) Submission for Innovative FMX314 Surgical Platform 100
6.59 Mar 23, 2016: MRI Interventions Announces 2015 Fourth Quarter and Full Year Results 101
6.60 Mar 21, 2016: Titan Medical Completes Underwriter's Exercise of Over-Allotment Option of Public Offering for USD13.3 Million 103
6.61 Mar 17, 2016: Gecko Biomedical Raises USD25 Million in Series A2 Financing 103
6.62 Mar 16, 2016: Intuitive Surgical Announces U.S. Clearance for da Vinci Xi Single-Site Instruments and Accessories 103
6.63 Mar 16, 2016: Surgical Innovations Group Announces Final results for year ended 31 December 2015 104
6.64 Mar 16, 2016: Life Spine Announces 45% Increase in Sales over the Past Six Months 107
6.65 Mar 03, 2016: TransEnterix Reports Operating Results for the Fourth Quarter and Full Year 2015 107
6.66 Mar 01, 2016: Duke Street to Acquire Medi-Globe 108
6.67 Feb 24, 2016: Globus Medical Reports Full Year and Fourth Quarter 2015 Results 108
6.68 Feb 24, 2016: LeMaitre Q4 2015 Record Sales $20.5mm (+14% organic), Record Net Income $2.5mm (+32%) 109
6.69 Feb 22, 2016: Syneron Medical Reports Record Fourth Quarter 2015 Revenue of $78.9 Million 111
6.70 Feb 18, 2016: ZSX Medical Raises USD0.7 Million in Venture Financing 112
6.71 Feb 12, 2016: Texas Institute for Robotic Surgery at St. David's North Austin Medical Center First in U.S. to Use Integrated Table Motion In Coordination With da Vinci Xi Surgical System 113
6.72 Feb 05, 2016: Vicarious Surgical Raises USD2.4 Million in Venture Financing 113
6.73 Feb 03, 2016: Titan Medical Completes Underwriter's Exercise of Over-Allotment Option of Public Offering for USD1 Million 113
6.74 Feb 02, 2016: Encision Reports Third Quarter Fiscal Year 2016 Results 114
6.75 Feb 01, 2016: TE Connectivity to Acquire Creganna Medical from Permira Advisers for USD895 Million 114
6.76 Jan 27, 2016: Johnson and Johnson May Acquire Transenterix 115
6.77 Jan 22, 2016: IlluminOss Medical Raises USD5 Million in Venture Financing 115
6.78 Jan 21, 2016: Intuitive Surgical Announces Fourth Quarter Earnings-2016 115
6.79 Jan 19, 2016: Globus Medical Announces Litigation Settlement Agreement 116
6.80 Jan 13, 2016: Intuitive Surgical Announces Preliminary Fourth Quarter and Full Year 2015 Results 116
6.81 Jan 11, 2016: Syneron Medical Provides Preliminary Fourth Quarter 2015 Revenue 117
6.82 Jan 07, 2016: MRI Interventions Announces 2015 Fourth Quarter and Full Year Revenues 117
6.83 Jan 06, 2016: Benvenue Medical Raises USD60 Million in Financing 118
6.84 Jan 06, 2016: Globus Medical Reports Preliminary Fourth Quarter and Full Year Record Sales Results 118
6.85 Dec 15, 2015: MRI Interventions to Raise USD5.2 Million in Private Placement of Units and Warrants 119
6.86 Dec 04, 2015: Medtronic Plans to Sell Assets of Covidien 119
6.87 Dec 03, 2015: NxThera Raises USD40 Million Financing 119
6.88 Nov 18, 2015: Major Expansion for Creganna Medical, Minnesota 119
6.89 Nov 15, 2015: CONMED Acquires SurgiQuest for USD265 Million 120
6.90 Nov 14, 2015: Phase I Inguinal Hernia Repair Clinical Trial 121
6.91 Nov 13, 2015: Titan Medical Announces Results for the Three and Nine Months Ended September 30, 2015 121
6.92 Nov 11, 2015: Syneron Medical Reports Third Quarter 2015 Revenue of $62.1 Million 121
6.93 Nov 10, 2015: DJO Global Announces Financial Results for Third Quarter 2015 122
6.94 Nov 05, 2015: Medrobotics Raises USD25 Million in Preferred Stock Financing 123
6.95 Nov 05, 2015: TransEnterix Reports Operating Results for the Third Quarter 2015 123
6.96 Nov 03, 2015: Titan Medical Raises USD9 Million in Public Offering of Units 124
6.97 Nov 03, 2015: MRI Interventions Announces 2015 Third Quarter Results 124
6.98 Nov 03, 2015: Globus Medical Reports Third Quarter 2015 Results 126
7 Appendix 128
7.1 Methodology 128
7.2 About GlobalData 130
7.3 Contact Us 130
7.4 Disclaimer 131

1.1 List of Tables
Table 1: Minimally Invasive Surgical (MIS) Devices - Pipeline Products by Stage of Development 10
Table 2: Minimally Invasive Surgical (MIS) Devices - Pipeline Products by Territory 11
Table 3: Minimally Invasive Surgical (MIS) Devices - Pipeline Products by Regulatory Path 12
Table 4: Minimally Invasive Surgical (MIS) Devices - Pipeline Products by Estimated Approval Date 13
Table 5: Minimally Invasive Surgical (MIS) Devices - Ongoing Clinical Trials 14
Table 6: Minimally Invasive Surgical (MIS) Devices Companies - Pipeline Products by Stage of Development 15
Table 7: Minimally Invasive Surgical (MIS) Devices - Pipeline Products by Stage of Development 17
Table 8: Actuated Medical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 18
Table 9: Grip-Act-Reposition (GAR) Miniaturized Stable Working Platform - Product Status 18
Table 10: Grip-Act-Reposition (GAR) Miniaturized Stable Working Platform - Product Description 19
Table 11: BriteSeed Pipeline Products and Ongoing Clinical Trials Overview 20
Table 12: SafeSnips - Product Status 20
Table 13: SafeSnips - Product Description 20
Table 14: Delft University of Technology Pipeline Products and Ongoing Clinical Trials Overview 21
Table 15: Endovascular Instrument - Product Status 21
Table 16: Endovascular Instrument - Product Description 21
Table 17: Fiber-Top Controlled Adaptable Stiffness Needle - Product Status 22
Table 18: Fiber-Top Controlled Adaptable Stiffness Needle - Product Description 22
Table 19: Low-friction Surgical Grasper - Product Status 22
Table 20: Low-friction Surgical Grasper - Product Description 23
Table 21: System With Shared Control Of Robotic Needle - Product Status 23
Table 22: System With Shared Control Of Robotic Needle - Product Description 23
Table 23: DistalMotion Pipeline Products and Ongoing Clinical Trials Overview 24
Table 24: Disposable Surgical Device - Product Status 24
Table 25: Disposable Surgical Device - Product Description 24
Table 26: Reusable Surgical Device - Product Status 25
Table 27: Reusable Surgical Device - Product Description 25
Table 28: ES Vascular Ltd. Pipeline Products and Ongoing Clinical Trials Overview 26
Table 29: CLI Endostapler - Product Status 26
Table 30: CLI Endostapler - Product Description 26
Table 31: Ethicon Endo-Surgery, Inc. Pipeline Products and Ongoing Clinical Trials Overview 27
Table 32: Magnetic Anchoring And Guidance System - Product Status 27
Table 33: Magnetic Anchoring And Guidance System - Product Description 27
Table 34: Eximis Pipeline Products and Ongoing Clinical Trials Overview 28
Table 35: XCor Specimen Removal Device - Product Status 28
Table 36: XCor Specimen Removal Device - Product Description 28
Table 37: FlexDex Pipeline Products and Ongoing Clinical Trials Overview 29
Table 38: FlexDex Needle Driver - Product Status 29
Table 39: FlexDex Needle Driver - Product Description 29
Table 40: Second Generation FlexDex needle Driver - Product Status 30
Table 41: Second Generation FlexDex needle Driver - Product Description 30
Table 42: Fortimedix B.V. Pipeline Products and Ongoing Clinical Trials Overview 31
Table 43: symphonX - Product Status 31
Table 44: symphonX - Product Description 31
Table 45: Hadassah Medical Center Pipeline Products and Ongoing Clinical Trials Overview 32
Table 46: Transdermal Antenna - Product Status 32
Table 47: Transdermal Antenna - Product Description 32
Table 48: Human Extensions LTD Pipeline Products and Ongoing Clinical Trials Overview 33
Table 49: Hand Avatar - Product Status 33
Table 50: Hand Avatar - Product Description 33
Table 51: Imperial College London Pipeline Products and Ongoing Clinical Trials Overview 34
Table 52: iSnake Surgical System - Product Status 34
Table 53: iSnake Surgical System - Product Description 34
Table 54: John Hopkins University Pipeline Products and Ongoing Clinical Trials Overview 35
Table 55: Dexterous Tool For Minimally Invasive Surgery - Product Status 35
Table 56: Dexterous Tool For Minimally Invasive Surgery - Product Description 35
Table 57: Osaka University Pipeline Products and Ongoing Clinical Trials Overview 36
Table 58: Minimal Access Surgical Instrument - Product Status 36
Table 59: Minimal Access Surgical Instrument - Product Description 36
Table 60: Rambam Health Care Campus Pipeline Products and Ongoing Clinical Trials Overview 37
Table 61: Surgical Device - Minimally Invasive Surgery - Product Status 37
Table 62: Surgical Device - Minimally Invasive Surgery - Product Description 37
Table 63: Signum Surgical Ltd Pipeline Products and Ongoing Clinical Trials Overview 38
Table 64: Signum Surgically Implanted Device - Product Status 38
Table 65: Signum Surgically Implanted Device - Product Description 38
Table 66: Technische Universiteit Eindhoven Pipeline Products and Ongoing Clinical Trials Overview 39
Table 67: PITON Teleoperated Steerable Needle - Product Status 39
Table 68: PITON Teleoperated Steerable Needle - Product Description 39
Table 69: UltraSurge Technologies Ltd. Pipeline Products and Ongoing Clinical Trials Overview 40
Table 70: UltraSurge's Device - Product Status 40
Table 71: UltraSurge's Device - Product Description 40
Table 72: University of California, San Francisco Pipeline Products and Ongoing Clinical Trials Overview 41
Table 73: Magnamosis - Compression Anastomosis - Product Status 41
Table 74: Magnamosis - Compression Anastomosis - Product Description 42
Table 75: University of California, San Francisco - Ongoing Clinical Trials Overview 43
Table 76: Magnamosis - Compression Anastomosis - Magnetic Compression Anastomosis (Magnamosis) First-in-human Study of Feasibility and Safety 44
Table 77: University of Wisconsin Madison Pipeline Products and Ongoing Clinical Trials Overview 45
Table 78: Interleaved Continuum-rigid Manipulator - Product Status 45
Table 79: Interleaved Continuum-rigid Manipulator - Product Description 46
Table 80: Varada Innovations Inc. Pipeline Products and Ongoing Clinical Trials Overview 47
Table 81: ArthroTense - Product Status 47
Table 82: ArthroTense - Product Description 47
Table 83: VenX Medical LLC Pipeline Products and Ongoing Clinical Trials Overview 48
Table 84: VenX Reach - Product Status 48
Table 85: VenX Reach - Product Description 48
Table 86: VenX Medical LLC - Ongoing Clinical Trials Overview 49
Table 87: VenX Reach - First-In-Man Study Using VenX Reach for the Treatment of Varicose Veins 50
Table 88: XACT Robotics Ltd. Pipeline Products and Ongoing Clinical Trials Overview 51
Table 89: XACT System - Product Status 51
Table 90: XACT System - Product Description 51
Table 91: Glossary 129

1.2 List of Figures
Figure 1: Minimally Invasive Surgical (MIS) Devices - Pipeline Products by Stage of Development 10
Figure 2: Minimally Invasive Surgical (MIS) Devices - Pipeline Products by Territory 11
Figure 3: Minimally Invasive Surgical (MIS) Devices - Pipeline Products by Regulatory Path 12
Figure 4: Minimally Invasive Surgical (MIS) Devices - Pipeline Products by Estimated Approval Date 13
Figure 5: Minimally Invasive Surgical (MIS) Devices - Ongoing Clinical Trials 14

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.